TESTING INTERVENTIONS TO IMPROVE ADHERENCE TO PHARMACOLOGICAL TREATMENT REGIMENS
Release Date: December 15, 1999
NOTICE: OD-00-005
National Institutes of Health
The National Institutes of Health (NIH) is implementing a trans-institute
initiative to improve adherence to therapeutic regimens. The Office of
Behavioral and Social Sciences Research, Office of the Director, NIH (OBSSR),
and several NIH Institutes are developing a Request for Applications (RFA) to
encourage behavioral and social research on the effectiveness of
interventions to improve adherence to therapeutic regimens involving
pharmacological treatments in various settings. The forthcoming RFA will
solicit regular research (R01) grant applications where (1) the therapeutic
regimen is for an existing illness or condition as opposed to a primary
disease prevention or health promotion regimen and (2) the adherence
intervention has been demonstrated to be effective in either (a) controlled
settings (e.g., laboratories, clinical trials), (b) has been tested only with
limited populations (e.g., small samples or samples from restricted
populations) or with short periods of follow-up, or (c) has been researched
on a health condition or treatment regimen different from that in the
proposed research. In addition, the RFA will encourage research on how to
adjust interventions to take into account the characteristics of different
patient groups as well as patients suffering from and receiving treatments
for multiple acute and/or chronic illnesses and conditions. The RFA will be
an opportunity to conduct research cutting across the traditional boundaries
of responsibility of the participating NIH Institutes and Centers (ICs).
The planned release date for the RFA is in late January 2000, with
applications being due in April 2000. OBSSR/NIH anticipates making available
$3 million for approximately six awards in September 2000.The announcement
will be published in the NIH Guide to Grants and Contracts in the usual
manner. You may also be informed of the publication of the RFA and receive
subsequent information by subscribing to the OBSSR’s automated e-mail
service. To subscribe, please send a message addressed to
[email protected]. Leave the subject line blank. The message body should
read SUBscribe RFA-ADHERENCE-L [your full name]. The message is case
sensitive, so capitalize as indicated! Don"t include the brackets. For
example, for Robin Smith to subscribe, the message would read SUBscribe RFA-
ADHERENCE-L Robin Smith (omit the quotation marks). You will receive a
confirmation of your subscription along with instructions on how to use the
LISTSERV and how to unsubscribe.
INQUIRIES
Please direct general inquiries in regard to this notice to:
Ronald P. Abeles, Ph.D.
Office of Behavioral and Social Sciences Research
Office of the Director
National Institutes of Health
Gateway Bldg., Rm. 2C234, MSC 9205
7201 Wisconsin Avenue
Bethesda, MD 20892-9205
Telephone: 301-496-7859
Fax: 301-435-8779
E-mail: [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
|
NIH... Turning Discovery Into Health®
|